2024 Antitrust in Healthcare
New Competition Theories in Life Sciences Mergers
The Ritz-Carlton, Pentagon City
06.05.2024 | 11:15 AM - 12:15 PM
Event Sponsor: American Bar Association
Recently, US merger enforcement agencies have challenged life sciences mergers using novel theories of harm. These include competition foreclosure by rebate bundling and acquisitions that stifle innovation. This panel will discuss these novel theories, their relevance in recent cases (e.g., Amgen/Horizon merger), and economic considerations and analyses to evaluate them.
Moderator:
- James Lee, Cornerstone Research, Los Angeles, CA
Speakers:
- John D. Carroll, Sheppard Mullin Richter & Hampton LLP, Washington, DC
- Renata B. Hesse, Sullivan & Cromwell LLP, Washington, DC
- Stephen Mohr, Assistant Director, Merger I, Federal Trade Commission, Washington, DC
Click here to register.